Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate Cancer-Reference-Cited by-同舟云学术

Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate Cancer

Published:2019-07-10 Issue:10 Volume:28 Page:1642-1651
ISSN:1055-9965
Container-title:Cancer Epidemiology Biomarkers & Prevention
language:en
Short-container-title:Cancer Epidemiol Biomarkers Prev

Author:

Haddad Bassem R.,Erickson Andrew,Udhane Vindhya,LaViolette Peter S.^ORCID,Rone Janice D.,Kallajoki Markku A.,See William A.,Rannikko Antti^ORCID,Mirtti Tuomas,Nevalainen Marja T.

Funder

HHS | NIH | National Cancer Institute (NCI)

Suomen Lääketieteen Säätiö (Finnish Medical Foundation)

Academy of Finland | Biotieteiden ja Ympäristön Tutkimuksen Toimikunta (Forskningsrådet för Biovetenskap och Miljö)

HUS Helsinki University Hospital grants

Advancing Healthier Wisconsin

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stat5 induces androgen receptor ( AR ) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling;Science Advances;2024-03

2. Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC;Nature Communications;2024-01-08

3. Small molecule STAT3/5 inhibitors exhibit therapeutic potential in acute myeloid leukemia and extra-nodal natural killer/T cell lymphoma;2023-10-18

4. Small molecule STAT3/5 inhibitors exhibit therapeutic potential in acute myeloid leukemia and extra-nodal natural killer/T cell lymphoma;2023-10-16

5. Influence of Systemic Therapy on the Expression and Activity of Selected STAT Proteins in Prostate Cancer Tissue;Life;2022-02-06